1. Home
  2. EMF vs CERS Comparison

EMF vs CERS Comparison

Compare EMF & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Templeton Emerging Markets Fund

EMF

Templeton Emerging Markets Fund

HOLD

Current Price

$22.39

Market Cap

253.7M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.53

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMF
CERS
Founded
1987
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
253.7M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
EMF
CERS
Price
$22.39
$2.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.1K
2.6M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
6.16%
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$13.31
$1.15
52 Week High
$22.57
$3.15

Technical Indicators

Market Signals
Indicator
EMF
CERS
Relative Strength Index (RSI) 77.57 64.90
Support Level $16.13 $1.78
Resistance Level N/A $2.68
Average True Range (ATR) 0.45 0.18
MACD 0.19 0.05
Stochastic Oscillator 96.83 51.92

Price Performance

Historical Comparison
EMF
CERS

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: